Sinusoidal obstruction syndrome diagnostic study of choice: Difference between revisions
Line 18: | Line 18: | ||
|- | |- | ||
| | | | ||
* | * Within 30 days of transplantation, bilirubinemia > 34.2 mol/L (2 mg/dL), plus 2 other findings among the following: | ||
* Hepatomegaly, usually painful | |||
* > 5% weight gain | |||
* Ascites | |||
{| class="wikitable" | |||
| Ascites | |||
|} | |||
| | | | ||
* < 200 mg/dl | * < 200 mg/dl |
Revision as of 20:05, 2 February 2018
Sinusoidal obstruction syndrome Microchapters |
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sinusoidal obstruction syndrome diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome diagnostic study of choice |
FDA on Sinusoidal obstruction syndrome diagnostic study of choice |
CDC on Sinusoidal obstruction syndrome diagnostic study of choice |
Sinusoidal obstruction syndrome diagnostic study of choice in the news |
Blogs on Sinusoidal obstruction syndrome diagnostic study of choice |
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
Risk calculators and risk factors for Sinusoidal obstruction syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Diagnostic Criteria
The diagnosis of sinusoidal obstruction syndrome should be considered in any patient who has undergone hematopoietic cell transplant and develops liver dysfunction.
- The two established criteria for the clinical diagnosis of sinusoidal obstruction syndrome are:
Baltimore Criteria | Seattle criteria | |
---|---|---|
|
| |
| ||
|
| |
| ||
|
| |
|
| |
|
| |
|
|